| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 182 | 2023 | 3079 | 10.310 |
Why?
|
| T-Lymphocytes, Regulatory | 40 | 2023 | 2988 | 4.390 |
Why?
|
| Autoimmunity | 33 | 2023 | 1350 | 4.140 |
Why?
|
| T-Lymphocytes | 127 | 2022 | 10183 | 4.010 |
Why?
|
| Autoimmune Diseases | 43 | 2023 | 2133 | 3.150 |
Why?
|
| T-Lymphocyte Subsets | 41 | 2023 | 1837 | 3.100 |
Why?
|
| Autoantigens | 35 | 2019 | 892 | 2.800 |
Why?
|
| CD4-Positive T-Lymphocytes | 44 | 2023 | 4386 | 2.650 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 15 | 2020 | 518 | 2.650 |
Why?
|
| Lymphocyte Activation | 86 | 2022 | 5524 | 2.560 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 28 | 2016 | 906 | 2.390 |
Why?
|
| Central Nervous System | 16 | 2022 | 1357 | 2.360 |
Why?
|
| Th17 Cells | 10 | 2018 | 766 | 2.250 |
Why?
|
| HLA-DR Antigens | 25 | 2012 | 645 | 2.140 |
Why?
|
| Forkhead Transcription Factors | 20 | 2023 | 1613 | 2.090 |
Why?
|
| Receptors, Interleukin-2 | 17 | 2006 | 573 | 1.820 |
Why?
|
| Th1 Cells | 13 | 2018 | 1057 | 1.810 |
Why?
|
| Clone Cells | 57 | 2021 | 1692 | 1.750 |
Why?
|
| Interleukin-17 | 9 | 2022 | 901 | 1.720 |
Why?
|
| Immune Tolerance | 29 | 2021 | 2259 | 1.600 |
Why?
|
| Neuroimmunomodulation | 4 | 2022 | 157 | 1.590 |
Why?
|
| CD8-Positive T-Lymphocytes | 24 | 2023 | 4479 | 1.550 |
Why?
|
| B-Lymphocytes | 25 | 2024 | 4666 | 1.520 |
Why?
|
| Antigens, CD | 33 | 2016 | 4026 | 1.470 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 16 | 2023 | 985 | 1.460 |
Why?
|
| Receptors, Virus | 6 | 2013 | 649 | 1.440 |
Why?
|
| Cytokines | 44 | 2023 | 7323 | 1.430 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 6 | 2011 | 310 | 1.350 |
Why?
|
| Histocompatibility Antigens Class II | 14 | 2021 | 1475 | 1.270 |
Why?
|
| Genetic Predisposition to Disease | 48 | 2023 | 17445 | 1.260 |
Why?
|
| Human T-lymphotropic virus 1 | 14 | 2001 | 140 | 1.240 |
Why?
|
| Receptors, Antigen, T-Cell | 43 | 2022 | 2540 | 1.210 |
Why?
|
| Interleukin-4 | 23 | 2006 | 1147 | 1.170 |
Why?
|
| Receptors, Immunologic | 14 | 2022 | 1423 | 1.150 |
Why?
|
| Antigens, Differentiation | 15 | 2007 | 927 | 1.140 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 20 | 2021 | 805 | 1.130 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 18 | 2014 | 834 | 1.070 |
Why?
|
| Sodium Chloride | 3 | 2021 | 625 | 1.060 |
Why?
|
| Interferon-gamma | 31 | 2018 | 3207 | 1.010 |
Why?
|
| Antigen Presentation | 14 | 2012 | 1284 | 1.010 |
Why?
|
| Self Tolerance | 4 | 2017 | 125 | 0.970 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2016 | 281 | 0.960 |
Why?
|
| Interleukin-10 | 16 | 2018 | 1200 | 0.950 |
Why?
|
| Inflammation | 20 | 2023 | 10636 | 0.930 |
Why?
|
| Humans | 410 | 2024 | 744376 | 0.880 |
Why?
|
| Myelin-Associated Glycoprotein | 7 | 2011 | 113 | 0.840 |
Why?
|
| Major Histocompatibility Complex | 17 | 2013 | 936 | 0.830 |
Why?
|
| Diabetes Mellitus, Type 1 | 14 | 2013 | 3338 | 0.830 |
Why?
|
| Immunologic Factors | 7 | 2018 | 1580 | 0.830 |
Why?
|
| Myelin Proteins | 15 | 2013 | 215 | 0.800 |
Why?
|
| Alleles | 25 | 2019 | 6933 | 0.790 |
Why?
|
| T-Lymphocytes, Cytotoxic | 5 | 2021 | 1821 | 0.770 |
Why?
|
| Membrane Glycoproteins | 16 | 2017 | 3771 | 0.770 |
Why?
|
| Epitopes, T-Lymphocyte | 9 | 2011 | 880 | 0.760 |
Why?
|
| Oleic Acid | 1 | 2021 | 85 | 0.760 |
Why?
|
| Autoantibodies | 17 | 2021 | 2036 | 0.760 |
Why?
|
| Immunoconjugates | 10 | 2008 | 901 | 0.760 |
Why?
|
| Flow Cytometry | 24 | 2023 | 5974 | 0.750 |
Why?
|
| Polymorphism, Single Nucleotide | 40 | 2020 | 15520 | 0.750 |
Why?
|
| Benzyl Compounds | 1 | 2019 | 20 | 0.730 |
Why?
|
| Interleukin-2 | 25 | 2017 | 1904 | 0.720 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2016 | 644 | 0.700 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 3 | 2018 | 40 | 0.680 |
Why?
|
| Cells, Cultured | 39 | 2022 | 19233 | 0.680 |
Why?
|
| Myelin Sheath | 9 | 2015 | 652 | 0.670 |
Why?
|
| Azetidines | 1 | 2019 | 142 | 0.650 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2014 | 140 | 0.640 |
Why?
|
| Interferon Type I | 2 | 2022 | 542 | 0.640 |
Why?
|
| HLA-A2 Antigen | 5 | 2003 | 213 | 0.630 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 4 | 2009 | 318 | 0.630 |
Why?
|
| Immunotherapy | 18 | 2021 | 4445 | 0.630 |
Why?
|
| Gene Expression Regulation | 19 | 2022 | 12073 | 0.630 |
Why?
|
| Gene Products, tax | 6 | 2003 | 51 | 0.620 |
Why?
|
| Peptides | 14 | 2012 | 4410 | 0.620 |
Why?
|
| Genetics, Population | 3 | 2022 | 934 | 0.600 |
Why?
|
| Membrane Proteins | 13 | 2014 | 7882 | 0.600 |
Why?
|
| Th2 Cells | 8 | 2013 | 1061 | 0.600 |
Why?
|
| Tumor Escape | 2 | 2017 | 350 | 0.600 |
Why?
|
| Antibodies, Monoclonal | 35 | 2023 | 9274 | 0.590 |
Why?
|
| Peptide Fragments | 19 | 2014 | 5096 | 0.580 |
Why?
|
| Immunophenotyping | 13 | 2021 | 1880 | 0.570 |
Why?
|
| Borrelia burgdorferi Group | 4 | 2001 | 97 | 0.560 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1038 | 0.550 |
Why?
|
| Immunologic Memory | 11 | 2010 | 1348 | 0.550 |
Why?
|
| Signal Transduction | 34 | 2016 | 23406 | 0.550 |
Why?
|
| Antigens, Surface | 13 | 2005 | 1663 | 0.540 |
Why?
|
| Cytotoxicity, Immunologic | 10 | 2021 | 1369 | 0.530 |
Why?
|
| Models, Immunological | 8 | 2016 | 527 | 0.530 |
Why?
|
| Paraparesis, Tropical Spastic | 6 | 1999 | 32 | 0.530 |
Why?
|
| Animals | 93 | 2023 | 168770 | 0.530 |
Why?
|
| Clonal Deletion | 1 | 2015 | 79 | 0.520 |
Why?
|
| Demyelinating Diseases | 8 | 2022 | 354 | 0.520 |
Why?
|
| Glutarates | 1 | 2017 | 236 | 0.520 |
Why?
|
| HTLV-I Infections | 7 | 2001 | 101 | 0.510 |
Why?
|
| Immune System | 4 | 2018 | 806 | 0.510 |
Why?
|
| Immunosuppressive Agents | 12 | 2015 | 4153 | 0.510 |
Why?
|
| Clonal Anergy | 4 | 2014 | 169 | 0.500 |
Why?
|
| Phenotype | 27 | 2024 | 16367 | 0.500 |
Why?
|
| Gene Expression Profiling | 15 | 2023 | 9445 | 0.490 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2014 | 172 | 0.480 |
Why?
|
| Lyme Disease | 6 | 2021 | 621 | 0.480 |
Why?
|
| Neurogenic Inflammation | 1 | 2014 | 33 | 0.470 |
Why?
|
| Single-Cell Analysis | 7 | 2023 | 2183 | 0.470 |
Why?
|
| Epitopes | 17 | 2023 | 2571 | 0.470 |
Why?
|
| Molecular Sequence Data | 42 | 2013 | 18111 | 0.460 |
Why?
|
| Arthritis, Rheumatoid | 9 | 2019 | 3712 | 0.460 |
Why?
|
| Inflammation Mediators | 5 | 2016 | 1888 | 0.450 |
Why?
|
| Cell Line, Transformed | 11 | 2012 | 898 | 0.450 |
Why?
|
| Coculture Techniques | 8 | 2015 | 1341 | 0.450 |
Why?
|
| beta Catenin | 1 | 2018 | 1059 | 0.450 |
Why?
|
| Cell Differentiation | 15 | 2016 | 11486 | 0.440 |
Why?
|
| Meninges | 2 | 2012 | 190 | 0.430 |
Why?
|
| Monocytes | 6 | 2016 | 2596 | 0.430 |
Why?
|
| Cell Separation | 9 | 2018 | 1751 | 0.430 |
Why?
|
| Genome-Wide Association Study | 26 | 2023 | 12262 | 0.420 |
Why?
|
| Interleukin-12 | 7 | 2011 | 580 | 0.420 |
Why?
|
| Chromosome Mapping | 11 | 2013 | 4740 | 0.420 |
Why?
|
| Macrophage Activation | 1 | 2015 | 560 | 0.420 |
Why?
|
| Transforming Growth Factor beta | 8 | 2009 | 2007 | 0.420 |
Why?
|
| Immunodominant Epitopes | 5 | 2000 | 267 | 0.420 |
Why?
|
| Myelin Proteolipid Protein | 9 | 1998 | 107 | 0.420 |
Why?
|
| Leukocytes, Mononuclear | 9 | 2023 | 1837 | 0.410 |
Why?
|
| Environment | 3 | 2019 | 1123 | 0.410 |
Why?
|
| Amino Acid Sequence | 33 | 2013 | 13814 | 0.410 |
Why?
|
| Cerebrospinal Fluid | 10 | 2018 | 535 | 0.410 |
Why?
|
| Propylene Glycols | 1 | 2012 | 92 | 0.410 |
Why?
|
| Candidiasis, Chronic Mucocutaneous | 1 | 2011 | 19 | 0.400 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 3596 | 0.400 |
Why?
|
| Glioblastoma | 5 | 2020 | 3481 | 0.390 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2011 | 69 | 0.390 |
Why?
|
| HLA Antigens | 6 | 2010 | 1382 | 0.380 |
Why?
|
| Microglia | 7 | 2022 | 1267 | 0.380 |
Why?
|
| RNA, Small Interfering | 6 | 2017 | 3505 | 0.360 |
Why?
|
| Interleukin-9 | 1 | 2010 | 63 | 0.360 |
Why?
|
| Immunity | 3 | 2016 | 1014 | 0.360 |
Why?
|
| Antigens | 9 | 2014 | 1466 | 0.360 |
Why?
|
| Genetic Variation | 14 | 2013 | 6542 | 0.350 |
Why?
|
| Sphingosine | 1 | 2012 | 307 | 0.350 |
Why?
|
| Antibody Formation | 5 | 2023 | 1402 | 0.350 |
Why?
|
| Dendritic Cells | 5 | 2014 | 2725 | 0.350 |
Why?
|
| Lipoproteins | 3 | 2005 | 878 | 0.350 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3647 | 0.350 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 3 | 2013 | 66 | 0.340 |
Why?
|
| Down-Regulation | 5 | 2014 | 3001 | 0.340 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 4 | 2015 | 264 | 0.330 |
Why?
|
| Haplotypes | 13 | 2020 | 2779 | 0.330 |
Why?
|
| Adult | 88 | 2021 | 214056 | 0.330 |
Why?
|
| Mice | 44 | 2023 | 81202 | 0.330 |
Why?
|
| Databases, Genetic | 2 | 2015 | 1783 | 0.330 |
Why?
|
| Case-Control Studies | 23 | 2016 | 21747 | 0.320 |
Why?
|
| Cross Reactions | 9 | 2004 | 841 | 0.320 |
Why?
|
| Immunomagnetic Separation | 2 | 2006 | 80 | 0.320 |
Why?
|
| Immediate-Early Proteins | 3 | 2017 | 453 | 0.320 |
Why?
|
| Interleukins | 3 | 2014 | 791 | 0.320 |
Why?
|
| Antigen-Presenting Cells | 12 | 2008 | 973 | 0.320 |
Why?
|
| Cathepsins | 1 | 2009 | 241 | 0.320 |
Why?
|
| B-Lymphocyte Subsets | 5 | 2012 | 246 | 0.310 |
Why?
|
| RNA, Messenger | 16 | 2023 | 13035 | 0.310 |
Why?
|
| Ligands | 9 | 2022 | 3282 | 0.310 |
Why?
|
| Clinical Trials as Topic | 6 | 2019 | 7914 | 0.310 |
Why?
|
| Lymph Nodes | 5 | 2014 | 3475 | 0.310 |
Why?
|
| Genotype | 22 | 2016 | 12952 | 0.300 |
Why?
|
| NF-kappa B | 2 | 2015 | 2499 | 0.290 |
Why?
|
| Bacterial Outer Membrane Proteins | 3 | 2005 | 404 | 0.290 |
Why?
|
| Gene Silencing | 5 | 2019 | 1539 | 0.290 |
Why?
|
| HLA-A Antigens | 4 | 2011 | 232 | 0.290 |
Why?
|
| Interferon-beta | 7 | 2014 | 324 | 0.290 |
Why?
|
| Sodium | 2 | 2023 | 1622 | 0.280 |
Why?
|
| Dose-Response Relationship, Immunologic | 6 | 2002 | 370 | 0.280 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 11 | 2016 | 3873 | 0.280 |
Why?
|
| Immunoglobulin G | 8 | 2023 | 4561 | 0.270 |
Why?
|
| Copyright | 1 | 2005 | 14 | 0.270 |
Why?
|
| Melanoma | 2 | 2022 | 5511 | 0.270 |
Why?
|
| Gene Frequency | 12 | 2019 | 3587 | 0.270 |
Why?
|
| Genetic Heterogeneity | 2 | 2009 | 733 | 0.270 |
Why?
|
| Cell Communication | 5 | 2013 | 1621 | 0.270 |
Why?
|
| STAT3 Transcription Factor | 4 | 2014 | 874 | 0.270 |
Why?
|
| Male | 93 | 2022 | 350118 | 0.270 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 3 | 2011 | 52 | 0.260 |
Why?
|
| Immunity, Innate | 9 | 2022 | 2962 | 0.260 |
Why?
|
| Female | 102 | 2024 | 380200 | 0.260 |
Why?
|
| Cell Division | 12 | 2004 | 4569 | 0.260 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 5692 | 0.260 |
Why?
|
| Cell Line | 24 | 2010 | 16000 | 0.260 |
Why?
|
| Medical Illustration | 1 | 2005 | 133 | 0.250 |
Why?
|
| Molecular Mimicry | 3 | 2001 | 201 | 0.250 |
Why?
|
| Antibodies | 9 | 2014 | 2460 | 0.240 |
Why?
|
| Glioma | 2 | 2017 | 3401 | 0.240 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 2 | 2006 | 236 | 0.240 |
Why?
|
| Killer Cells, Natural | 6 | 2021 | 2133 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2009 | 658 | 0.240 |
Why?
|
| Middle Aged | 66 | 2021 | 213388 | 0.240 |
Why?
|
| Lectins, C-Type | 3 | 2017 | 589 | 0.240 |
Why?
|
| Complementarity Determining Regions | 2 | 2001 | 149 | 0.240 |
Why?
|
| Macrophages | 5 | 2015 | 5660 | 0.230 |
Why?
|
| Cell Proliferation | 9 | 2022 | 10484 | 0.230 |
Why?
|
| Toll-Like Receptors | 4 | 2014 | 593 | 0.230 |
Why?
|
| Antibodies, Heterophile | 2 | 2001 | 126 | 0.230 |
Why?
|
| CD40 Ligand | 3 | 2022 | 526 | 0.230 |
Why?
|
| Systems Biology | 3 | 2016 | 469 | 0.230 |
Why?
|
| Neuroprotective Agents | 2 | 2007 | 941 | 0.230 |
Why?
|
| Lymphotoxin-alpha | 1 | 2003 | 98 | 0.220 |
Why?
|
| Interleukin-5 | 4 | 2000 | 273 | 0.220 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 5 | 1997 | 113 | 0.220 |
Why?
|
| HLA-DR2 Antigen | 4 | 1995 | 48 | 0.220 |
Why?
|
| Lymphocytes | 6 | 2014 | 2617 | 0.210 |
Why?
|
| Antibody Affinity | 1 | 2003 | 254 | 0.210 |
Why?
|
| GATA3 Transcription Factor | 2 | 2013 | 157 | 0.210 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2016 | 2560 | 0.210 |
Why?
|
| Body Fluids | 1 | 2024 | 319 | 0.210 |
Why?
|
| Disease Susceptibility | 5 | 2014 | 1782 | 0.210 |
Why?
|
| Gene Expression | 8 | 2021 | 7798 | 0.210 |
Why?
|
| Protein Binding | 9 | 2014 | 9384 | 0.200 |
Why?
|
| Immunosorbent Techniques | 1 | 2001 | 184 | 0.200 |
Why?
|
| Colitis | 2 | 2023 | 1170 | 0.200 |
Why?
|
| Genomics | 3 | 2016 | 5717 | 0.200 |
Why?
|
| Pancreas | 2 | 2005 | 1687 | 0.200 |
Why?
|
| Interleukin-6 | 8 | 2016 | 3203 | 0.200 |
Why?
|
| Erythema Chronicum Migrans | 1 | 2021 | 47 | 0.200 |
Why?
|
| Herpesvirus 4, Human | 6 | 2009 | 1041 | 0.190 |
Why?
|
| Glutamate Decarboxylase | 1 | 2002 | 245 | 0.190 |
Why?
|
| Exanthema Subitum | 1 | 2000 | 4 | 0.190 |
Why?
|
| Chemokine CXCL10 | 3 | 2017 | 305 | 0.190 |
Why?
|
| Monitoring, Immunologic | 1 | 2021 | 100 | 0.190 |
Why?
|
| Lymphatic System | 1 | 2022 | 252 | 0.190 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 205 | 0.190 |
Why?
|
| Immunoassay | 3 | 2010 | 752 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2015 | 4424 | 0.190 |
Why?
|
| Central Nervous System Diseases | 2 | 1999 | 518 | 0.180 |
Why?
|
| Dinoprostone | 2 | 2014 | 601 | 0.180 |
Why?
|
| Genetic Testing | 5 | 2012 | 3444 | 0.180 |
Why?
|
| Interferon Regulatory Factors | 3 | 2011 | 270 | 0.180 |
Why?
|
| Linkage Disequilibrium | 8 | 2013 | 1997 | 0.180 |
Why?
|
| Cyclophosphamide | 8 | 1998 | 2242 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 4 | 1996 | 343 | 0.180 |
Why?
|
| Infectious Mononucleosis | 1 | 2000 | 131 | 0.180 |
Why?
|
| Interleukin-1 | 4 | 1992 | 1263 | 0.180 |
Why?
|
| Tetanus Toxoid | 7 | 2004 | 193 | 0.180 |
Why?
|
| Base Sequence | 19 | 2014 | 12797 | 0.180 |
Why?
|
| Antigens, Viral | 3 | 2000 | 1035 | 0.180 |
Why?
|
| Gene Regulatory Networks | 2 | 2022 | 1708 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 4751 | 0.180 |
Why?
|
| Immunity, Cellular | 6 | 2011 | 1607 | 0.170 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2022 | 548 | 0.170 |
Why?
|
| Administration, Oral | 14 | 1997 | 3914 | 0.170 |
Why?
|
| Brain | 16 | 2022 | 26386 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 4 | 2023 | 2012 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 11 | 2019 | 21833 | 0.170 |
Why?
|
| beta-Synuclein | 1 | 2019 | 14 | 0.170 |
Why?
|
| Sirolimus | 4 | 2003 | 1565 | 0.170 |
Why?
|
| Proinsulin | 1 | 1999 | 133 | 0.170 |
Why?
|
| Neuroglia | 3 | 2022 | 928 | 0.170 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2019 | 53 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 1656 | 0.170 |
Why?
|
| Adaptive Immunity | 2 | 2022 | 714 | 0.160 |
Why?
|
| Kinetics | 6 | 2007 | 6476 | 0.160 |
Why?
|
| Proteolipids | 4 | 1997 | 117 | 0.160 |
Why?
|
| Brain Neoplasms | 3 | 2017 | 8862 | 0.160 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2018 | 107 | 0.160 |
Why?
|
| Phosphorylation | 10 | 2014 | 8437 | 0.160 |
Why?
|
| Cricetinae | 7 | 2008 | 2475 | 0.160 |
Why?
|
| Aedes | 1 | 2019 | 100 | 0.160 |
Why?
|
| Intestinal Diseases | 1 | 2023 | 530 | 0.160 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 1997 | 97 | 0.160 |
Why?
|
| HIV Infections | 4 | 2018 | 16715 | 0.160 |
Why?
|
| Immunoglobulin Variable Region | 4 | 2011 | 421 | 0.160 |
Why?
|
| CHO Cells | 6 | 2002 | 1409 | 0.160 |
Why?
|
| Nuclear Family | 1 | 2019 | 318 | 0.150 |
Why?
|
| International Cooperation | 1 | 2004 | 1420 | 0.150 |
Why?
|
| Astrocytes | 3 | 2018 | 1273 | 0.150 |
Why?
|
| Lymphocyte Culture Test, Mixed | 6 | 1995 | 518 | 0.150 |
Why?
|
| Status Epilepticus | 1 | 2023 | 444 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2009 | 3921 | 0.150 |
Why?
|
| Tissue Array Analysis | 2 | 2010 | 553 | 0.150 |
Why?
|
| Computational Biology | 3 | 2021 | 3519 | 0.150 |
Why?
|
| Nervous System | 1 | 2001 | 554 | 0.150 |
Why?
|
| Disease Progression | 11 | 2024 | 13285 | 0.150 |
Why?
|
| Lymphocyte Count | 4 | 2001 | 793 | 0.150 |
Why?
|
| Isoenzymes | 1 | 2002 | 1728 | 0.150 |
Why?
|
| Plasma Cells | 3 | 2023 | 591 | 0.150 |
Why?
|
| Chemokine CXCL9 | 1 | 2017 | 132 | 0.150 |
Why?
|
| Immunoglobulins | 5 | 2011 | 881 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2006 | 2850 | 0.140 |
Why?
|
| HIV-1 | 1 | 2014 | 6939 | 0.140 |
Why?
|
| Chlamydia Infections | 1 | 2000 | 365 | 0.140 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2020 | 895 | 0.140 |
Why?
|
| Amino Acid Substitution | 3 | 2011 | 1793 | 0.140 |
Why?
|
| Disease | 1 | 2022 | 680 | 0.140 |
Why?
|
| Blood Proteins | 1 | 2001 | 1124 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2009 | 403 | 0.140 |
Why?
|
| Interleukin-1beta | 3 | 2014 | 972 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 320 | 0.130 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 612 | 0.130 |
Why?
|
| Fetal Proteins | 1 | 2016 | 94 | 0.130 |
Why?
|
| Adrenocorticotropic Hormone | 6 | 1993 | 648 | 0.130 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2019 | 2104 | 0.130 |
Why?
|
| Antigens, CD1 | 4 | 2005 | 437 | 0.130 |
Why?
|
| Histocompatibility Antigens | 3 | 2006 | 471 | 0.130 |
Why?
|
| Chemokines | 3 | 2023 | 970 | 0.130 |
Why?
|
| Insulin | 3 | 2010 | 6582 | 0.130 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2016 | 150 | 0.130 |
Why?
|
| Database Management Systems | 1 | 2016 | 270 | 0.130 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1730 | 0.130 |
Why?
|
| JC Virus | 1 | 2015 | 85 | 0.130 |
Why?
|
| S Phase | 3 | 1996 | 423 | 0.130 |
Why?
|
| Liver Transplantation | 2 | 2016 | 2119 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 10 | 2009 | 6171 | 0.130 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 2 | 1993 | 43 | 0.130 |
Why?
|
| Herpesviridae Infections | 1 | 1996 | 277 | 0.130 |
Why?
|
| Genome | 1 | 2023 | 1807 | 0.120 |
Why?
|
| DNA Primers | 6 | 2003 | 2891 | 0.120 |
Why?
|
| Risk Factors | 11 | 2023 | 72295 | 0.120 |
Why?
|
| Vaccines | 1 | 2023 | 823 | 0.120 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2016 | 141 | 0.120 |
Why?
|
| Young Adult | 14 | 2018 | 56434 | 0.120 |
Why?
|
| Benzeneacetamides | 1 | 2014 | 39 | 0.120 |
Why?
|
| West Nile virus | 1 | 2014 | 82 | 0.120 |
Why?
|
| Herpes Zoster | 3 | 1998 | 264 | 0.120 |
Why?
|
| L-Selectin | 2 | 2005 | 214 | 0.120 |
Why?
|
| Genes, X-Linked | 1 | 2014 | 128 | 0.120 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2014 | 39 | 0.120 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 266 | 0.120 |
Why?
|
| Apraxias | 1 | 2014 | 64 | 0.120 |
Why?
|
| Receptors, CCR6 | 1 | 2014 | 81 | 0.120 |
Why?
|
| Transcription, Genetic | 9 | 2017 | 7722 | 0.120 |
Why?
|
| Polymorphism, Genetic | 8 | 2009 | 4328 | 0.120 |
Why?
|
| Antibody Specificity | 4 | 2013 | 1095 | 0.120 |
Why?
|
| Herpesvirus 6, Human | 2 | 2007 | 95 | 0.120 |
Why?
|
| Solubility | 3 | 2009 | 1088 | 0.120 |
Why?
|
| United States Food and Drug Administration | 2 | 2019 | 1584 | 0.120 |
Why?
|
| Antigens, CD1d | 3 | 2005 | 220 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 2 | 1998 | 204 | 0.110 |
Why?
|
| Lysosomes | 2 | 2009 | 893 | 0.110 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2010 | 828 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2010 | 3465 | 0.110 |
Why?
|
| STAT Transcription Factors | 1 | 2014 | 182 | 0.110 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 298 | 0.110 |
Why?
|
| Digoxin | 1 | 2014 | 250 | 0.110 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2013 | 173 | 0.110 |
Why?
|
| Adoptive Transfer | 1 | 2015 | 844 | 0.110 |
Why?
|
| Granzymes | 1 | 2014 | 271 | 0.110 |
Why?
|
| Transcription Factors | 4 | 2022 | 12209 | 0.110 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1996 | 524 | 0.110 |
Why?
|
| Methylprednisolone | 3 | 1999 | 387 | 0.110 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 297 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2014 | 224 | 0.110 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2009 | 570 | 0.110 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 381 | 0.110 |
Why?
|
| Quantitative Trait Loci | 5 | 2014 | 2019 | 0.110 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2012 | 44 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 3 | 2019 | 4464 | 0.110 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2014 | 274 | 0.100 |
Why?
|
| Bacterial Vaccines | 3 | 2005 | 403 | 0.100 |
Why?
|
| Dexamethasone | 1 | 1999 | 1951 | 0.100 |
Why?
|
| Recombinant Proteins | 7 | 2019 | 6621 | 0.100 |
Why?
|
| HLA-D Antigens | 5 | 2008 | 134 | 0.100 |
Why?
|
| Immunoglobulin M | 3 | 2021 | 1537 | 0.100 |
Why?
|
| Antigens, Bacterial | 2 | 1998 | 1172 | 0.100 |
Why?
|
| Encephalomyelitis | 2 | 1991 | 34 | 0.100 |
Why?
|
| Meningoencephalitis | 2 | 1989 | 78 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2013 | 903 | 0.100 |
Why?
|
| G2 Phase | 1 | 1991 | 139 | 0.100 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 871 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1547 | 0.100 |
Why?
|
| Europe | 5 | 2016 | 3339 | 0.100 |
Why?
|
| Lyme Disease Vaccines | 2 | 2001 | 18 | 0.100 |
Why?
|
| Genome, Human | 10 | 2011 | 4420 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 625 | 0.100 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 1832 | 0.100 |
Why?
|
| Oligopeptides | 1 | 1996 | 1189 | 0.100 |
Why?
|
| Genetic Markers | 6 | 2014 | 2634 | 0.100 |
Why?
|
| RNA Interference | 3 | 2015 | 2891 | 0.100 |
Why?
|
| Interleukin-23 | 2 | 2012 | 194 | 0.100 |
Why?
|
| Protein Kinase C | 2 | 1993 | 1227 | 0.090 |
Why?
|
| Acetylesterase | 1 | 2010 | 14 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 1993 | 821 | 0.090 |
Why?
|
| RNA | 3 | 2023 | 2749 | 0.090 |
Why?
|
| Ventricular Dysfunction | 1 | 2011 | 143 | 0.090 |
Why?
|
| Organ Specificity | 4 | 2019 | 2008 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 1061 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2014 | 894 | 0.090 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2010 | 26 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 3 | 1999 | 1602 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 175 | 0.090 |
Why?
|
| Leukocyte Count | 4 | 2006 | 1588 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4851 | 0.090 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2010 | 31 | 0.090 |
Why?
|
| Neuritis | 1 | 1990 | 36 | 0.090 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2010 | 98 | 0.090 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2010 | 87 | 0.090 |
Why?
|
| Microsatellite Repeats | 4 | 2007 | 802 | 0.090 |
Why?
|
| Aged | 29 | 2023 | 163284 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 1 | 2012 | 517 | 0.090 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 18034 | 0.090 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 504 | 0.090 |
Why?
|
| Adolescent | 19 | 2021 | 85784 | 0.090 |
Why?
|
| Nervous System Diseases | 3 | 1994 | 1622 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 697 | 0.090 |
Why?
|
| Speech | 1 | 2014 | 541 | 0.090 |
Why?
|
| Blood Donors | 1 | 2012 | 355 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2011 | 354 | 0.090 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 3 | 2001 | 379 | 0.090 |
Why?
|
| Probiotics | 1 | 2013 | 351 | 0.090 |
Why?
|
| Blotting, Southern | 4 | 1997 | 803 | 0.090 |
Why?
|
| Albuterol | 1 | 2010 | 208 | 0.090 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2010 | 181 | 0.090 |
Why?
|
| Up-Regulation | 5 | 2020 | 4222 | 0.090 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2011 | 440 | 0.090 |
Why?
|
| Complement C7 | 1 | 2009 | 17 | 0.090 |
Why?
|
| Interleukin-7 | 1 | 2010 | 142 | 0.090 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 471 | 0.090 |
Why?
|
| Protein Transport | 1 | 2015 | 1988 | 0.090 |
Why?
|
| TYK2 Kinase | 1 | 2009 | 38 | 0.090 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 1 | 2009 | 16 | 0.090 |
Why?
|
| Cluster Analysis | 4 | 2023 | 2715 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2004 | 587 | 0.080 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 1678 | 0.080 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 1999 | 33 | 0.080 |
Why?
|
| Cell Polarity | 2 | 2010 | 645 | 0.080 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 354 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2013 | 1366 | 0.080 |
Why?
|
| Desensitization, Immunologic | 1 | 1994 | 483 | 0.080 |
Why?
|
| Odds Ratio | 8 | 2020 | 9849 | 0.080 |
Why?
|
| Kallikreins | 1 | 2010 | 258 | 0.080 |
Why?
|
| Virus Diseases | 2 | 2008 | 711 | 0.080 |
Why?
|
| Galectins | 2 | 2009 | 268 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2008 | 10943 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 14723 | 0.080 |
Why?
|
| Titrimetry | 1 | 2007 | 36 | 0.080 |
Why?
|
| Sequence Analysis | 1 | 2009 | 256 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2703 | 0.080 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 1987 | 24 | 0.080 |
Why?
|
| Antibodies, Blocking | 2 | 2017 | 253 | 0.080 |
Why?
|
| Antibodies, Viral | 2 | 2015 | 3177 | 0.080 |
Why?
|
| Calcium | 4 | 2014 | 5755 | 0.080 |
Why?
|
| Cervical Vertebrae | 1 | 2014 | 976 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 1525 | 0.080 |
Why?
|
| Immunization | 2 | 2004 | 1256 | 0.080 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 845 | 0.080 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2009 | 165 | 0.080 |
Why?
|
| Models, Biological | 5 | 2012 | 9584 | 0.080 |
Why?
|
| Apoptosis | 5 | 2008 | 9726 | 0.080 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2007 | 23 | 0.080 |
Why?
|
| Neprilysin | 1 | 2010 | 439 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2504 | 0.080 |
Why?
|
| Artifacts | 1 | 2016 | 1904 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2014 | 2216 | 0.070 |
Why?
|
| Immunoglobulin Switch Region | 1 | 2007 | 46 | 0.070 |
Why?
|
| Poliovirus | 1 | 1987 | 109 | 0.070 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 738 | 0.070 |
Why?
|
| Immune System Diseases | 1 | 2009 | 261 | 0.070 |
Why?
|
| Brain Diseases | 1 | 1996 | 1563 | 0.070 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 57 | 0.070 |
Why?
|
| Phosphotyrosine | 1 | 2007 | 457 | 0.070 |
Why?
|
| Models, Statistical | 3 | 2021 | 5101 | 0.070 |
Why?
|
| Mutation | 5 | 2017 | 29786 | 0.070 |
Why?
|
| Drug Discovery | 1 | 2015 | 1058 | 0.070 |
Why?
|
| Thymidine | 2 | 1998 | 310 | 0.070 |
Why?
|
| HLA-DQ Antigens | 2 | 1999 | 210 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2007 | 380 | 0.070 |
Why?
|
| Radiography | 2 | 2015 | 7023 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2016 | 2926 | 0.070 |
Why?
|
| Mitosis | 1 | 1991 | 1208 | 0.070 |
Why?
|
| Recurrence | 6 | 2023 | 8340 | 0.070 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2008 | 311 | 0.070 |
Why?
|
| Structure-Activity Relationship | 3 | 2014 | 3130 | 0.070 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2007 | 262 | 0.070 |
Why?
|
| Radioimmunoassay | 2 | 2005 | 919 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2009 | 634 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2015 | 2969 | 0.070 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2009 | 491 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2011 | 971 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2014 | 14561 | 0.070 |
Why?
|
| Hypergammaglobulinemia | 1 | 1986 | 74 | 0.070 |
Why?
|
| Hybridomas | 2 | 2004 | 452 | 0.070 |
Why?
|
| Synovial Fluid | 2 | 2005 | 394 | 0.070 |
Why?
|
| Algorithms | 5 | 2016 | 13882 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 3037 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 1978 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2008 | 1157 | 0.070 |
Why?
|
| Equipment Failure Analysis | 3 | 2016 | 868 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2015 | 2585 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1157 | 0.070 |
Why?
|
| Influenza, Human | 2 | 2014 | 1479 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2008 | 563 | 0.060 |
Why?
|
| Diet | 2 | 2014 | 7937 | 0.060 |
Why?
|
| Binding Sites | 3 | 2003 | 6111 | 0.060 |
Why?
|
| Interleukin-13 | 2 | 2010 | 389 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 1504 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 2647 | 0.060 |
Why?
|
| Cysteine | 1 | 2010 | 873 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1480 | 0.060 |
Why?
|
| Myeloid Cells | 2 | 2021 | 810 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 3706 | 0.060 |
Why?
|
| Genetic Linkage | 3 | 2005 | 2421 | 0.060 |
Why?
|
| Child | 14 | 2021 | 77708 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 1213 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2016 | 2029 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2009 | 1252 | 0.060 |
Why?
|
| Neoplasms | 3 | 2022 | 21693 | 0.060 |
Why?
|
| Treatment Failure | 4 | 2022 | 2618 | 0.060 |
Why?
|
| Time Factors | 11 | 2015 | 40077 | 0.060 |
Why?
|
| Software | 3 | 2014 | 4442 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 35424 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2011 | 1318 | 0.060 |
Why?
|
| Drug Resistance | 3 | 2010 | 1608 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2009 | 743 | 0.060 |
Why?
|
| HTLV-I Antibodies | 2 | 1995 | 35 | 0.060 |
Why?
|
| Tetralogy of Fallot | 1 | 2009 | 623 | 0.060 |
Why?
|
| Encephalitis | 3 | 1988 | 425 | 0.060 |
Why?
|
| Myositis | 1 | 2007 | 251 | 0.060 |
Why?
|
| Apoproteins | 2 | 1996 | 44 | 0.060 |
Why?
|
| Cyclin D | 1 | 2003 | 72 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 565 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 473 | 0.060 |
Why?
|
| Annexin A5 | 1 | 2003 | 103 | 0.060 |
Why?
|
| RNA, Viral | 3 | 2022 | 2901 | 0.060 |
Why?
|
| Phytohemagglutinins | 3 | 1998 | 170 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2006 | 338 | 0.060 |
Why?
|
| Fluoresceins | 1 | 2003 | 235 | 0.060 |
Why?
|
| Receptors, Transferrin | 1 | 2005 | 296 | 0.060 |
Why?
|
| Chemokine CCL3 | 1 | 2023 | 84 | 0.060 |
Why?
|
| Remission Induction | 1 | 2009 | 2386 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3617 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2005 | 457 | 0.060 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2008 | 745 | 0.060 |
Why?
|
| Age Factors | 3 | 2015 | 18373 | 0.060 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2002 | 42 | 0.060 |
Why?
|
| Graft vs Host Disease | 1 | 2015 | 2958 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3326 | 0.050 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2022 | 27 | 0.050 |
Why?
|
| Genetic Loci | 4 | 2014 | 2575 | 0.050 |
Why?
|
| Receptors, CXCR5 | 1 | 2023 | 92 | 0.050 |
Why?
|
| Forecasting | 1 | 2012 | 2951 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 323 | 0.050 |
Why?
|
| Esters | 1 | 2003 | 210 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 286 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5868 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 1723 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 1788 | 0.050 |
Why?
|
| Dipeptidyl Peptidase 4 | 2 | 1993 | 91 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4208 | 0.050 |
Why?
|
| Child, Preschool | 9 | 2021 | 41005 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2008 | 2377 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 6387 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2003 | 411 | 0.050 |
Why?
|
| Antigens, CD20 | 1 | 2023 | 199 | 0.050 |
Why?
|
| Uveitis | 2 | 1997 | 375 | 0.050 |
Why?
|
| Vaccination | 4 | 2023 | 3279 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2011 | 2288 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 3 | 1995 | 1799 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2007 | 2428 | 0.050 |
Why?
|
| Proteome | 1 | 2012 | 1798 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2008 | 1352 | 0.050 |
Why?
|
| Receptors, CXCR3 | 1 | 2023 | 237 | 0.050 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2002 | 200 | 0.050 |
Why?
|
| Antilymphocyte Serum | 1 | 2023 | 492 | 0.050 |
Why?
|
| Binomial Distribution | 1 | 2021 | 25 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2009 | 3749 | 0.050 |
Why?
|
| Proviruses | 2 | 1994 | 318 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 3 | 2010 | 1000 | 0.050 |
Why?
|
| Transfection | 4 | 2004 | 5895 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 667 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2014 | 3188 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 603 | 0.050 |
Why?
|
| Exons | 4 | 2010 | 2439 | 0.050 |
Why?
|
| Obesity | 2 | 2014 | 12745 | 0.050 |
Why?
|
| Double-Blind Method | 6 | 2022 | 12025 | 0.050 |
Why?
|
| Mice, Transgenic | 6 | 2016 | 9735 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2003 | 566 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1802 | 0.050 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2000 | 71 | 0.050 |
Why?
|
| Epistasis, Genetic | 2 | 2015 | 365 | 0.050 |
Why?
|
| DNA Repair | 1 | 2010 | 2046 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 2916 | 0.050 |
Why?
|
| Epitope Mapping | 2 | 1999 | 311 | 0.050 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2000 | 55 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 2938 | 0.050 |
Why?
|
| Sural Nerve | 1 | 2000 | 106 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2008 | 1988 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 203 | 0.050 |
Why?
|
| Theilovirus | 1 | 1999 | 11 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 595 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2022 | 1271 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 11366 | 0.040 |
Why?
|
| Cardiovirus Infections | 1 | 1999 | 19 | 0.040 |
Why?
|
| Equipment Design | 3 | 2016 | 3582 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2010 | 2926 | 0.040 |
Why?
|
| Cell Movement | 3 | 2023 | 5218 | 0.040 |
Why?
|
| Biopolymers | 1 | 2000 | 189 | 0.040 |
Why?
|
| Longitudinal Studies | 4 | 2013 | 13988 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2003 | 692 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1999 | 347 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2001 | 2256 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 4 | 2014 | 4805 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3751 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 2 | 2016 | 944 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1801 | 0.040 |
Why?
|
| United States | 5 | 2019 | 69869 | 0.040 |
Why?
|
| Cohort Studies | 8 | 2021 | 40558 | 0.040 |
Why?
|
| Twins | 1 | 2000 | 339 | 0.040 |
Why?
|
| Insect Bites and Stings | 1 | 2019 | 67 | 0.040 |
Why?
|
| Logistic Models | 5 | 2011 | 13409 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 1999 | 171 | 0.040 |
Why?
|
| DNA | 7 | 1999 | 7294 | 0.040 |
Why?
|
| Troponin | 1 | 2022 | 524 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 1981 | 390 | 0.040 |
Why?
|
| Endothelium | 1 | 2021 | 778 | 0.040 |
Why?
|
| Triplets | 1 | 1998 | 43 | 0.040 |
Why?
|
| Subacute Sclerosing Panencephalitis | 2 | 1988 | 24 | 0.040 |
Why?
|
| Graft Survival | 1 | 2008 | 3737 | 0.040 |
Why?
|
| Microfluidics | 1 | 2023 | 662 | 0.040 |
Why?
|
| Binding Sites, Antibody | 3 | 2005 | 349 | 0.040 |
Why?
|
| Cattle | 4 | 1997 | 3922 | 0.040 |
Why?
|
| Arrestin | 1 | 1997 | 30 | 0.040 |
Why?
|
| Salivary Glands | 1 | 2019 | 229 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2018 | 275 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2004 | 5181 | 0.040 |
Why?
|
| Sample Size | 2 | 2011 | 845 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 1677 | 0.040 |
Why?
|
| Coma | 1 | 1981 | 475 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 1999 | 391 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2001 | 3702 | 0.040 |
Why?
|
| Alkylating Agents | 1 | 1997 | 139 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2000 | 673 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2022 | 15535 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 1919 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1434 | 0.040 |
Why?
|
| Skin | 2 | 2021 | 4371 | 0.040 |
Why?
|
| Polyenes | 2 | 1996 | 69 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 1999 | 1202 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2011 | 25628 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2000 | 1101 | 0.030 |
Why?
|
| Leukemia, T-Cell | 2 | 1993 | 104 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 1998 | 458 | 0.030 |
Why?
|
| Blood | 1 | 2018 | 598 | 0.030 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1998 | 279 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1998 | 449 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 1999 | 670 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1997 | 567 | 0.030 |
Why?
|
| Reference Values | 1 | 2003 | 4982 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2021 | 1438 | 0.030 |
Why?
|
| Thymoma | 1 | 1997 | 186 | 0.030 |
Why?
|
| Rats | 3 | 2008 | 24252 | 0.030 |
Why?
|
| Enterotoxins | 2 | 1995 | 368 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2014 | 2504 | 0.030 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2014 | 44 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2008 | 4397 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 2887 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5857 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2000 | 685 | 0.030 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 314 | 0.030 |
Why?
|
| Saliva | 1 | 2019 | 809 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2014 | 38 | 0.030 |
Why?
|
| Androstenols | 1 | 2014 | 25 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 19905 | 0.030 |
Why?
|
| Spleen | 1 | 2000 | 2362 | 0.030 |
Why?
|
| Glycosylation | 1 | 1997 | 1128 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1997 | 268 | 0.030 |
Why?
|
| Neurologic Examination | 2 | 1995 | 931 | 0.030 |
Why?
|
| Heat-Shock Proteins | 3 | 1995 | 822 | 0.030 |
Why?
|
| Colombia | 1 | 1995 | 258 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2014 | 378 | 0.030 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1994 | 42 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1809 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 708 | 0.030 |
Why?
|
| Rheumatic Fever | 1 | 2014 | 71 | 0.030 |
Why?
|
| Phorbol Esters | 1 | 2013 | 111 | 0.030 |
Why?
|
| Western World | 1 | 2013 | 27 | 0.030 |
Why?
|
| Jurkat Cells | 2 | 2009 | 743 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15295 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 2014 | 402 | 0.030 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2014 | 90 | 0.030 |
Why?
|
| Age of Onset | 3 | 2009 | 3270 | 0.030 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1993 | 16 | 0.030 |
Why?
|
| Yogurt | 1 | 2013 | 72 | 0.030 |
Why?
|
| Cyclosporine | 2 | 1996 | 788 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 435 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 496 | 0.030 |
Why?
|
| Sequence Analysis, Protein | 1 | 2014 | 258 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 1998 | 728 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2006 | 2304 | 0.030 |
Why?
|
| Drug Therapy, Combination | 5 | 2010 | 6489 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2014 | 212 | 0.030 |
Why?
|
| G-Protein-Coupled Receptor Kinase 1 | 1 | 2012 | 8 | 0.030 |
Why?
|
| Suicide, Attempted | 1 | 1981 | 1218 | 0.030 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 2204 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3799 | 0.030 |
Why?
|
| Comorbidity | 3 | 2014 | 10388 | 0.030 |
Why?
|
| Proteomics | 1 | 2006 | 3638 | 0.030 |
Why?
|
| Chronic Disease | 4 | 1998 | 9145 | 0.030 |
Why?
|
| Tacrolimus | 2 | 1996 | 743 | 0.030 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2012 | 41 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2015 | 720 | 0.030 |
Why?
|
| Virus Integration | 1 | 1994 | 299 | 0.030 |
Why?
|
| Staurosporine | 1 | 1993 | 251 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 541 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 1994 | 455 | 0.030 |
Why?
|
| Alkaloids | 1 | 1993 | 190 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1994 | 1375 | 0.030 |
Why?
|
| Peptide Library | 1 | 2013 | 349 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2016 | 6194 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 411 | 0.020 |
Why?
|
| Cell Death | 1 | 1997 | 1707 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 1994 | 291 | 0.020 |
Why?
|
| Telomere | 1 | 2017 | 910 | 0.020 |
Why?
|
| Fast Foods | 1 | 2013 | 197 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2014 | 582 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1995 | 982 | 0.020 |
Why?
|
| Lipids | 1 | 2022 | 3307 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1999 | 4010 | 0.020 |
Why?
|
| Pilot Projects | 3 | 2010 | 8319 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 1994 | 705 | 0.020 |
Why?
|
| Glutamine | 1 | 2013 | 579 | 0.020 |
Why?
|
| Mitogens | 1 | 1990 | 232 | 0.020 |
Why?
|
| Influenza A virus | 1 | 2014 | 456 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 147 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1999 | 2108 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2014 | 1526 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2013 | 767 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 528 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 9647 | 0.020 |
Why?
|
| Quantum Theory | 1 | 2010 | 70 | 0.020 |
Why?
|
| Arginine | 1 | 2013 | 944 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 167 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 141 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 1872 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2014 | 895 | 0.020 |
Why?
|
| Reoviridae | 2 | 1987 | 161 | 0.020 |
Why?
|
| DNA Probes | 1 | 1991 | 560 | 0.020 |
Why?
|
| Point Mutation | 1 | 1995 | 1624 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 1454 | 0.020 |
Why?
|
| Lymphokines | 1 | 1992 | 949 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 2004 | 4320 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 2839 | 0.020 |
Why?
|
| Eosinophils | 1 | 2014 | 955 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2012 | 1005 | 0.020 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2009 | 43 | 0.020 |
Why?
|
| Arthritis, Infectious | 1 | 1993 | 367 | 0.020 |
Why?
|
| Epigenomics | 1 | 2014 | 903 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 3773 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2009 | 259 | 0.020 |
Why?
|
| Paramyxoviridae Infections | 1 | 2009 | 55 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2010 | 346 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 326 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 1991 | 608 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2015 | 1534 | 0.020 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2009 | 50 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2013 | 739 | 0.020 |
Why?
|
| Janus Kinases | 1 | 2009 | 244 | 0.020 |
Why?
|
| Biopsy | 2 | 2000 | 6755 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2009 | 323 | 0.020 |
Why?
|
| Genome, Viral | 1 | 1992 | 667 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 3390 | 0.020 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1988 | 158 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 6314 | 0.020 |
Why?
|
| Bacteria | 1 | 2019 | 2115 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1341 | 0.020 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1987 | 33 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1783 | 0.020 |
Why?
|
| Finland | 1 | 2009 | 602 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 1790 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2009 | 500 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 1656 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2016 | 4777 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1084 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1989 | 2255 | 0.020 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2008 | 150 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 479 | 0.020 |
Why?
|
| Alzheimer Disease | 2 | 2021 | 8038 | 0.020 |
Why?
|
| Pokeweed Mitogens | 1 | 1986 | 38 | 0.020 |
Why?
|
| Gene Library | 1 | 2009 | 1074 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2015 | 2740 | 0.020 |
Why?
|
| Lentivirus | 1 | 2009 | 503 | 0.020 |
Why?
|
| Mumps virus | 1 | 1986 | 24 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2011 | 1343 | 0.020 |
Why?
|
| C-Peptide | 1 | 2008 | 419 | 0.020 |
Why?
|
| Microdissection | 1 | 2007 | 152 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1988 | 349 | 0.020 |
Why?
|
| Infusions, Intravenous | 2 | 1988 | 2274 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 1987 | 342 | 0.020 |
Why?
|
| Skin Tests | 1 | 1988 | 613 | 0.020 |
Why?
|
| Retina | 1 | 1997 | 2616 | 0.020 |
Why?
|
| Syndecan-1 | 1 | 2007 | 165 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 1990 | 541 | 0.020 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2006 | 87 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 4933 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2009 | 435 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 91 | 0.020 |
Why?
|
| Fluoroimmunoassay | 1 | 2005 | 33 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2009 | 538 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2010 | 694 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2006 | 65 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2011 | 1185 | 0.020 |
Why?
|
| Portal Vein | 1 | 2008 | 437 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 9957 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1986 | 219 | 0.020 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2005 | 32 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2014 | 880 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2009 | 598 | 0.020 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2010 | 428 | 0.020 |
Why?
|
| Drug Approval | 1 | 2012 | 742 | 0.020 |
Why?
|
| Biological Assay | 1 | 1988 | 652 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2016 | 2921 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 1993 | 1453 | 0.020 |
Why?
|
| Collagen | 1 | 1993 | 2688 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2007 | 758 | 0.020 |
Why?
|
| Solutions | 1 | 2005 | 426 | 0.020 |
Why?
|
| Autopsy | 1 | 2008 | 1020 | 0.020 |
Why?
|
| Reoviridae Infections | 1 | 1984 | 60 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1364 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2184 | 0.010 |
Why?
|
| Risk | 3 | 2006 | 9688 | 0.010 |
Why?
|
| Intestines | 1 | 2013 | 1924 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 791 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3508 | 0.010 |
Why?
|
| Sensation | 1 | 1986 | 336 | 0.010 |
Why?
|
| Family Health | 1 | 2009 | 1281 | 0.010 |
Why?
|
| Acute Disease | 2 | 1992 | 7147 | 0.010 |
Why?
|
| Follow-Up Studies | 5 | 1999 | 39052 | 0.010 |
Why?
|
| Blotting, Northern | 2 | 1998 | 1581 | 0.010 |
Why?
|
| Atrophy | 1 | 2008 | 1584 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 817 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1851 | 0.010 |
Why?
|
| Paralysis | 1 | 2005 | 247 | 0.010 |
Why?
|
| Age Distribution | 1 | 2009 | 2902 | 0.010 |
Why?
|
| Protein Folding | 1 | 2007 | 840 | 0.010 |
Why?
|
| Tandem Repeat Sequences | 1 | 2004 | 185 | 0.010 |
Why?
|
| Causality | 1 | 2009 | 1275 | 0.010 |
Why?
|
| Chromatin | 1 | 2014 | 2934 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 4255 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10259 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2009 | 2373 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2022 | 53291 | 0.010 |
Why?
|
| Minnesota | 1 | 2003 | 344 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1986 | 446 | 0.010 |
Why?
|
| Australia | 1 | 2005 | 1167 | 0.010 |
Why?
|
| Life Style | 1 | 2014 | 3835 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4287 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1681 | 0.010 |
Why?
|
| Flurazepam | 1 | 1981 | 8 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2014 | 4217 | 0.010 |
Why?
|
| Chlordiazepoxide | 1 | 1981 | 42 | 0.010 |
Why?
|
| Heterozygote | 1 | 2008 | 2804 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 57776 | 0.010 |
Why?
|
| Joints | 1 | 2003 | 326 | 0.010 |
Why?
|
| Pedigree | 1 | 2009 | 4642 | 0.010 |
Why?
|
| Canada | 1 | 2006 | 2065 | 0.010 |
Why?
|
| Paraplegia | 1 | 1981 | 169 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2014 | 2775 | 0.010 |
Why?
|
| Cell Cycle | 2 | 1999 | 2968 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2011 | 3024 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 1982 | 407 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 25041 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2004 | 1879 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3759 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2009 | 2566 | 0.010 |
Why?
|
| Spinal Puncture | 1 | 1981 | 281 | 0.010 |
Why?
|
| Treatment Outcome | 4 | 2011 | 63115 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 5882 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 12961 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16692 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2003 | 1117 | 0.010 |
Why?
|
| Liver | 1 | 1993 | 7475 | 0.010 |
Why?
|
| Life Tables | 1 | 1997 | 370 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2009 | 3817 | 0.010 |
Why?
|
| Infant | 1 | 1998 | 35134 | 0.010 |
Why?
|
| Janus Kinase 3 | 1 | 1996 | 78 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 1997 | 337 | 0.010 |
Why?
|
| Guinea Pigs | 2 | 1991 | 1386 | 0.010 |
Why?
|
| Injections, Intradermal | 1 | 1996 | 117 | 0.010 |
Why?
|
| Spinal Diseases | 1 | 1981 | 538 | 0.010 |
Why?
|
| Hematoma | 1 | 1981 | 758 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 2873 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1997 | 647 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1420 | 0.010 |
Why?
|
| Superantigens | 1 | 1995 | 129 | 0.010 |
Why?
|
| Cricetulus | 1 | 1996 | 818 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1994 | 313 | 0.010 |
Why?
|
| G1 Phase | 1 | 1996 | 415 | 0.010 |
Why?
|
| Family | 1 | 2005 | 3147 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1996 | 719 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 4185 | 0.010 |
Why?
|
| Mesentery | 1 | 1994 | 205 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 4772 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1997 | 640 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15078 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1981 | 1018 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 1996 | 490 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 427 | 0.010 |
Why?
|
| Safety | 1 | 1997 | 1186 | 0.010 |
Why?
|
| Methotrexate | 1 | 1997 | 1728 | 0.010 |
Why?
|
| Phylogeny | 1 | 1998 | 2804 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1991 | 484 | 0.010 |
Why?
|
| Serotonin | 1 | 1994 | 1017 | 0.010 |
Why?
|
| Seizures | 1 | 1982 | 2859 | 0.010 |
Why?
|
| Boston | 1 | 2003 | 9312 | 0.010 |
Why?
|
| Placebo Effect | 1 | 1993 | 502 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1991 | 1162 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 23336 | 0.000 |
Why?
|
| Leukopenia | 1 | 1988 | 213 | 0.000 |
Why?
|
| Prognosis | 1 | 2008 | 29060 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 2010 | 77459 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1994 | 2227 | 0.000 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1996 | 2455 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1996 | 6366 | 0.000 |
Why?
|
| Research Design | 2 | 1996 | 5986 | 0.000 |
Why?
|
| Herpes Simplex | 1 | 1988 | 470 | 0.000 |
Why?
|
| Ependyma | 1 | 1984 | 54 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1999 | 7730 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1987 | 1267 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1984 | 2505 | 0.000 |
Why?
|
| Placebos | 1 | 1984 | 1676 | 0.000 |
Why?
|
| Astrocytoma | 1 | 1982 | 790 | 0.000 |
Why?
|
| Frontal Lobe | 1 | 1982 | 1406 | 0.000 |
Why?
|
| Anticoagulants | 1 | 1981 | 4600 | 0.000 |
Why?
|